Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 295 M298 M287 M305 M306 M343 M 1.24 B Research & development —————— — Operating income 129 M112 M-24 M-508 M38 M1.13 B 631 M Non-Operating Income, Total 0000-4 M-2 M -6 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 0000-3 M-2 M -5 M Unusual income/expense 0000-1 M0 -1 M Pretax income 827 M848 M878 M-299 M883 M916 M 2.38 B Equity in earnings —————— — Taxes 45 M25 M3 M-65 M23 M37 M -2 M Non-controlling/minority interest 1 M00000 0 After tax other income/expense —————— — Net income before discontinued operations 56 M69 M-2 M-431 M22 M77 M -334 M Discontinued operations —————— — Net income 56 M69 M-2 M-431 M22 M77 M -334 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 61 M74 M-2 M-441 M22 M81 M -340 M Basic earnings per share (Basic EPS) 1.61.98-0.07-12.350.642.21 -9.57 Diluted earnings per share (Diluted EPS) 1.461.77-0.07-120.642.12 -9.31 Average basic shares outstanding 35.1 M34.9 M34.9 M34.9 M34.5 M34.8 M — Diluted shares outstanding 42 M41.7 M34.9 M34.9 M34.8 M38.2 M — EBITDA 134 M119 M39 M-383 M93 M169 M -82 M EBIT 129 M112 M33 M-451 M88 M161 M -169 M Cost of revenue 50 M58 M57 M57 M50 M72 M 236 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 5 M7 M6 M68 M5 M8 M 87 M